Agreement is poor among current criteria used to define response to cardiac resynchronization therapy

Brandon K Fornwalt1, William W Sprague, Patrick BeDell

  • 1Emory University School of Medicine, Department of Radiology, Atlanta, GA 30322, USA. bkf@gatech.edu

Circulation
|April 28, 2010
PubMed

Insights

Agreement on cardiac resynchronization therapy response criteria is poor. Most studies use different definitions, hindering consistent results and patient outcome comparisons.

Area of Science:

  • Cardiology
  • Medical Device Technology
  • Clinical Trials

Background:

  • Multiple criteria exist for defining positive response to cardiac resynchronization therapy (CRT).
  • No prior studies have assessed the agreement among these diverse response criteria.
  • This study hypothesized poor agreement among various CRT response criteria.

Purpose of the Study:

  • To evaluate the agreement among different response criteria for cardiac resynchronization therapy.
  • To quantify the variability in response rates based on differing definitions.

Main Methods:

  • Conducted a literature search for "cardiac resynchronization" and "response" to identify relevant articles.
  • Reviewed 50 highly-cited publications, extracting 17 distinct primary response criteria from 26 articles.
  • Assessed agreement among 15 criteria using Cohen's kappa-coefficient in 426 patients from the PROSPECT study.

Main Results:

  • The overall response rate to CRT varied widely, from 32% to 91% across the 15 assessed criteria.
  • Seventy-five percent of comparisons between criteria showed poor agreement (kappa ≤ 0.4).
  • Only 4% of comparisons demonstrated strong agreement (kappa ≥ 0.75), with moderate agreement in 21%.

Conclusions:

  • Cardiac resynchronization therapy response is defined by 17 different criteria in the most cited literature.
  • Poor agreement (75%) and limited strong agreement (4%) among these criteria hinder the generalizability of study findings.
  • The lack of consensus on response criteria complicates the interpretation and comparison of CRT outcomes across studies.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753